Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management.
ACRODAT®
AcroQOL
GH
IGF-1
SAGIT®
Journal
Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
11
10
2021
accepted:
07
03
2022
pubmed:
25
3
2022
medline:
14
9
2022
entrez:
24
3
2022
Statut:
ppublish
Résumé
Acromegaly is a rare chronic disease characterized by systemic comorbidity and reduced quality of life. Although achieving biochemical control has always been the primary goal of acromegaly therapy, recent evidence has shown that the traditional assessment does not adequately capture the complexity of symptoms and patients' perception. These findings result in the need to improve a fast decision-making process of the clinician, who should not only take into account biochemical-instrumental criteria, but also patients' symptoms. With the aim of supporting the clinician in the diagnostic and therapeutic decision-making process several disease-specific tools have been developed. The aim of this review is to provide a description of the acromegaly-specific tools, presenting their main features, their application in daily practice, and their efficacy and utility. A systematic search of Medline/PubMed, ISI-Web of Knowledge, and Google Scholar databases was done. Specific instruments and questionnaires have recently been developed to assist clinicians in the assessment of acromegaly. These are either Patient-Reported Outcome tools, such as Acromegaly Quality of Life Questionnaire (AcroQoL) and Pain Assessment Acromegaly Symptom Questionnaire (PASQ), or Clinician-Reported Outcome tools, such as ACROSCORE, SAGIT Questionnaires and tools are useful in the management of acromegaly patients. They help clinicians evaluate patients' symptoms and could assist in the evaluation of disease activity.
Identifiants
pubmed: 35322391
doi: 10.1007/s40618-022-01782-x
pii: 10.1007/s40618-022-01782-x
pmc: PMC9463243
doi:
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1823-1834Informations de copyright
© 2022. The Author(s).
Références
Clin Endocrinol (Oxf). 2021 Jan;94(1):58-65
pubmed: 32779234
J Investig Med. 2018 Mar;66(3):653-660
pubmed: 29151042
Eur J Health Econ. 2021 Dec;22(9):1381-1391
pubmed: 33988760
J Endocrinol Invest. 2016 Nov;39(11):1277-1284
pubmed: 27153851
Eur J Endocrinol. 2006 Aug;155(2):269-77
pubmed: 16868140
Pituitary. 2011 Dec;14(4):328-34
pubmed: 21328081
Pituitary. 2016 Feb;19(1):39-49
pubmed: 26377024
Int J Endocrinol. 2020 Aug 04;2020:5363849
pubmed: 32831834
J Med Econ. 2018 Apr;21(4):382-389
pubmed: 29261359
Clin Endocrinol (Oxf). 2002 Aug;57(2):251-8
pubmed: 12153605
Endocr Connect. 2020 Aug;9(8):824-833
pubmed: 32738132
Value Health. 2014 Nov;17(7):A355
pubmed: 27200705
Eur J Endocrinol. 2008 May;158(5):587-93
pubmed: 18426816
Endocrine. 2019 Nov;66(2):301-309
pubmed: 31317523
Endocrine. 2019 Dec;66(3):634-641
pubmed: 31473920
Nat Rev Endocrinol. 2018 Sep;14(9):552-561
pubmed: 30050156
N Engl J Med. 2000 Apr 20;342(16):1171-7
pubmed: 10770982
Pituitary. 2017 Dec;20(6):692-701
pubmed: 28887782
J Clin Endocrinol Metab. 2011 Nov;96(11):3550-8
pubmed: 21917873
Pituitary. 2019 Oct;22(5):476-487
pubmed: 31338660
Clin Endocrinol (Oxf). 2007 Sep;67(3):358-62
pubmed: 17555502
Eur J Endocrinol. 2015 Jul;173(1):37-42
pubmed: 25872514
Clin Endocrinol (Oxf). 2016 Mar;84(3):380-5
pubmed: 26433136
J Clin Endocrinol Metab. 2021 Jan 23;106(2):577-587
pubmed: 33245343
Pituitary. 2020 Apr;23(2):140-148
pubmed: 31808101
Pituitary. 2022 Feb;25(1):159-166
pubmed: 34518997
Clin Endocrinol (Oxf). 2017 Jun;86(6):806-815
pubmed: 28316090
Pituitary. 2020 Aug;23(4):347-358
pubmed: 32221764
Pituitary. 2016 Apr;19(2):149-57
pubmed: 26603536
Endocrine. 2014 Nov;47(2):564-71
pubmed: 24510628
Indian J Endocrinol Metab. 2020 Sep-Oct;24(5):402-405
pubmed: 33489844
Psychol Res Behav Manag. 2019 Jan 03;12:39-44
pubmed: 30655710
Pituitary. 2015 Dec;18(6):916-23
pubmed: 26224528
Clin Endocrinol (Oxf). 2008 Jul;69(1):123-8
pubmed: 18182092
Growth Horm IGF Res. 2010 Jun;20(3):226-33
pubmed: 20194043
Endokrynol Pol. 2017;68(5):524-532
pubmed: 28879648
Endocrinol Diabetes Metab. 2021 Feb 03;4(2):e00229
pubmed: 33855226
J Clin Endocrinol Metab. 2008 Oct;93(10):3853-9
pubmed: 18647806
Pituitary. 2015 Jun;18(3):366-75
pubmed: 24965695
J Endocrinol Invest. 2010 Jan;33(1):20-5
pubmed: 20203538
Neuroendocrinology. 2006;83(3-4):224-9
pubmed: 17047387
Pituitary. 2019 Feb;22(1):62-69
pubmed: 30627944
Neuroendocrinology. 2021;111(8):775-785
pubmed: 32980840
Eur J Endocrinol. 2020 Mar;182(3):319-331
pubmed: 31958318
Front Endocrinol (Lausanne). 2015 Jan 06;5:229
pubmed: 25610427
J Back Musculoskelet Rehabil. 2021;34(3):441-451
pubmed: 33492273
Endocr Connect. 2014 Apr 15;3(2):85-92
pubmed: 24692508
Eur J Endocrinol. 2015 May;172(5):583-93
pubmed: 25724922
Pituitary. 2014 Dec;17(6):557-63
pubmed: 24337714
Pituitary. 2019 Dec;22(6):581-593
pubmed: 31522359
Rev Endocr Metab Disord. 2020 Dec;21(4):667-678
pubmed: 32914330
Endocrine. 2015 Aug;49(3):774-82
pubmed: 25561370
Endocrine. 2020 Dec;70(3):575-583
pubmed: 32725444
Growth Horm IGF Res. 2015 Oct;25(5):219-26
pubmed: 26164770
Exp Clin Endocrinol Diabetes. 2011 May;119(5):300-5
pubmed: 21031340
Pituitary. 2021 Oct;24(5):768-777
pubmed: 33982222
Pituitary. 2019 Oct;22(5):552-560
pubmed: 31032537
J Clin Endocrinol Metab. 2021 Nov 19;106(12):3555-3568
pubmed: 34313752
J Formos Med Assoc. 2019 Nov;118(11):1488-1493
pubmed: 31147197
BMC Endocr Disord. 2020 Jul 31;20(1):117
pubmed: 32736547
Eur J Endocrinol. 2008 Mar;158(3):305-10
pubmed: 18299462
Acta Neurochir (Wien). 2013 Sep;155(9):1637-45; discussion 1645
pubmed: 23836354
Endocrine. 2020 Jul;69(1):165-174
pubmed: 32333268
Clin Endocrinol (Oxf). 2005 Jul;63(1):103-10
pubmed: 15963069
Pituitary. 2014 Dec;17(6):495-9
pubmed: 24178448
J Clin Endocrinol Metab. 2021 Jan 1;106(1):211-225
pubmed: 33079177
Eur J Endocrinol. 2007 Oct;157(4):411-7
pubmed: 17893254
Pituitary. 2012 Jun;15(2):179-83
pubmed: 21380935
Endocr J. 2013;60(6):753-61
pubmed: 23391571
Front Endocrinol (Lausanne). 2021 Mar 15;12:627711
pubmed: 33790860